Table 2.
Summary of findings: PS vs T-piece SBTs on SBT and extubation success
Outcome | Illustrative comparative risksa (95% CI) | Risk ratio (95% CI) | Number of participants (trials) | Quality of evidence (GRADE) | |
---|---|---|---|---|---|
Assumed risk, T-piece | Corresponding risk, pressure support | ||||
PS vs T-piece SBTs on SBT success | Study population | 1.00 (0.89–1.11) | 1901 (9 trials) | ⊕ ⊕ ⊕⊝ moderateb | |
766 per 1000 | 766 per 1000 (681–850) | ||||
PS vs T-piece SBTs on extubation success | Study population | 1.06 (1.02–1.1) | 1904 (11 trials) | ⊕ ⊕ ⊕⊝ moderatec | |
749 per 1000 | 794d per 1000 (764–824) |
PS pressure support, CI confidence interval, SBT spontaneous breathing trial, GRADE Grading of Recommendations Assessment, Development and Evaluation, NNT number needed to treat
aThe assumed risk is based on the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). NNT is 1000/(794–749) = 22 (95% CI 13–67)
bThe Chittawatanarat [47] trial skews data, increases heterogeneity, and changes summary estimate of effect. It also changes our interpretation of the findings
cMethodologic concerns with the Colombo trial (quasi-randomized) [34]; this trial carries 10% weight in the pooled extubation outcome meta-analysis
dCorresponds to NNT of 794–749 = 45 or 1000/45 = 22 (95% CI 13–67)